Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation

References

• Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, Gazelle GS, Huertas JC, Stuart KE, Jacobs T, Torchillin VP, et al. Percutaneous tumor ablation: Increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002; 222: 797–804
   PubMed Web of Science ®Google Scholar
• Gustafson DL, Rastatter JC, Colombo T, Long ME. Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic model. J Pharm Sci 2002; 91: 488–501
   Web of Science ®Google Scholar
• Ahmed M, Lukyanov AN, Torchilin V, Tournier H, Schneider AN, Goldberg SN. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: Effect of chemotherapeutic agent, nanoparticle size, and circulation time. J Vasc Interv Radiol 2005; 16: 1365–1371
   PubMed Web of Science ®Google Scholar
• Ponce AM, Viglianti BL, Yu D, Yarmolenko PS, Michelich CR, Woo J, Bally MB, Dewhirst MW. Magnetic resonance imaging of temperature-sensitive liposome release: Drug dose painting and antitumor effects. J Natl Cancer Inst 2007; 99: 53–63
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Saldinger PF, Gazelle GS, Huertas JC, Stuart KE, Jacobs T, Kruskal JB. Percutaneous tumor ablation: Increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Radiology 2001; 220: 420–427
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, Stuart KE, Ahmed M, Raptopoulos V. Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgeno 2002; 179: 93–101
   PubMed Web of Science ®Google Scholar
• Lammers T, Hennink WE, Storm G. Tumour-targeted nanomedicines: Principles and practice. Br J Cancer 2008; 99: 392–397
   PubMed Web of Science ®Google Scholar
• Thigpen JT, Aghajanian CA, Alberts DS, Campos SM, Gordon AN, Markman M, McMeekin DS, Monk BJ, Rose PG. Role of pegylated liposomal doxorubicin in ovarian cancer. Gynecol Oncol 2005; 96: 10–18
   PubMed Web of Science ®Google Scholar
• Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 1988; 85: 6949–6953
   PubMed Web of Science ®Google Scholar
• Weinstein JN, Magin RL, Yatvin MB, Zaharko DS. Liposomes and local hyperthermia: Selective delivery of methotrexate to heated tumors. Science 1979; 204: 188–191
   PubMed Web of Science ®Google Scholar
• Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 2001; 53: 285–305
   PubMed Web of Science ®Google Scholar
• Mills JK, Needham D. The materials engineering of temperature-sensitive liposomes. Methods Enzymol 2004; 387: 82–113
   PubMed Web of Science ®Google Scholar
• El-Kareh AW, Secomb TW. A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells. Neoplasia 2000; 2: 325–338
   PubMed Web of Science ®Google Scholar
• Jackson TL. Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model. J Theor Biol 2003; 220: 201–213
   PubMed Web of Science ®Google Scholar
• Qian F, Saidel GM, Sutton DM, Exner A, Gao J. Combined modeling and experimental approach for the development of dual-release polymer millirods. J Control Release 2002; 83: 427–435
   PubMed Web of Science ®Google Scholar
• Qian F, Stowe N, Liu EH, Saidel GM, Gao J. Quantification of in vivo doxorubicin transport from PLGA millirods in thermoablated rat livers. J Control Release 2003; 91: 157–166
   PubMed Web of Science ®Google Scholar
• El-Kareh AW, Secomb TW. Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin. Neoplasia 2005; 7: 705–713
   PubMed Web of Science ®Google Scholar
• Ahmed M, Liu Z, Humphries S, Goldberg SN. Computer modeling of the combined effects of perfusion, electrical conductivity and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int J Hyperthermia 2008; 24: 577–588
   PubMed Web of Science ®Google Scholar
• Altrogge I, Preusser T, Kroger T, Buskens C, Pereira PL, Schmidt D, Peitgen HO. Multiscale optimization of the probe placement for radiofrequency ablation. Acad Radiol 2007; 14: 1310–1324
   PubMed Web of Science ®Google Scholar
• Barauskas R, Gulbinas A, Vanagas T, Barauskas G. Finite element modeling of cooled-tip probe radiofrequency ablation processes in liver tissue. Comput Biol Med 2008; 38: 694–708
   PubMed Web of Science ®Google Scholar
• Chen CC, Miga MI, Galloway RL, Jr. Optimizing electrode placement using finite-element models in radiofrequency ablation treatment planning. IEEE Trans Biomed Eng 2009; 56: 237–245
   PubMed Web of Science ®Google Scholar
• Hariharan P, Chang I, Myers MR, Banerjee RK. Radio-frequency ablation in a realistic reconstructed hepatic tissue. J Biomech EngTrans ASME 2007; 129: 354–364
   PubMed Web of Science ®Google Scholar
• Schutt DJ, Haemmerich D. Effects of variation in perfusion rates and of perfusion models in computational models of radio frequency tumor ablation. Med Phys 2008; 35: 3462–3470
   PubMed Web of Science ®Google Scholar
• Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1948; 1: 93–122
   PubMed Web of Science ®Google Scholar
• Arkin H, Xu LX, Holmes KR. Recent developments in modeling heat transfer in blood perfused tissues. IEEE Trans Biomed Eng 1994; 41: 97–107
   PubMed Web of Science ®Google Scholar
• Valvano JW, Cochran JR, Diller KR. Thermal conductivity and diffusivity of biomaterials measured with self-heated thermistors. Int J Thermophys 1985; 6: 301–311
   Web of Science ®Google Scholar
• Duck F. Thermal properties of tissue. Physical Properties of Tissue. Academic Press, London 1990; 167–223
   Google Scholar
• Haemmerich D, Chachati L, Wright AS, Mahvi DM, Lee FT Jr, Webster JG. Hepatic radiofrequency ablation with internally cooled probes: Effect of coolant temperature on lesion size. IEEE Trans Biomed Eng 2003; 50: 493–500
   PubMed Web of Science ®Google Scholar
• Yang D, Converse MC, Mahvi DM, Webster JG. Expanding the bioheat equation to include tissue internal water evaporation during heating. IEEE Trans Biomed Eng 2007; 54: 1382–1388
   PubMed Web of Science ®Google Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 1984; 44: S4721–4730
   PubMed Web of Science ®Google Scholar
• Brown SL, Hunt JW, Hill RP. Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia. Int J Hyperthermia 1992; 8: 501–514
   PubMed Web of Science ®Google Scholar
• Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: Dynamic CT measurements correlated with disease severity. Am J Roentgenol 2001; 176: 667–673
   PubMed Web of Science ®Google Scholar
• Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004; 11: 215–223
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223–232
   PubMed Web of Science ®Google Scholar
• Brizel DM, Klitzman B, Cook JM, Edwards J, Rosner G, Dewhirst MW. A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys 1993; 25: 269–276
   PubMed Web of Science ®Google Scholar
• Sparano JA, Speyer J, Gradishar WJ, Liebes L, Sridhara R, Mendoza S, Fry D, Egorin MJ. Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer. J Clin Oncol 1999; 17: 880–886
   PubMed Web of Science ®Google Scholar
• Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: A novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009; 10: 333–343
   PubMed Web of Science ®Google Scholar
• Doroshow JH. Anthracyclines and anthracenediones. Cancer Chemotherapy and Biotherapy: Principles and Practice, BA LDL Chabner. Lippincott Williams & Wilkins, Philadelphia 2006
   Google Scholar
• Sylven B, Bois I. Protein content and enzymatic assays of interstitial fluid from some normal tissues and transplanted mouse tumors. Cancer Res 1960; 20: 831–836
   PubMed Web of Science ®Google Scholar
• Yuan F, Leunig M, Berk DA, Jain RK. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 1993; 45: 269–289
   PubMed Web of Science ®Google Scholar
• Jain RK. Transport of molecules in the tumor interstitium: A review. Cancer Res 1987; 47: 3039–3051
   PubMed Web of Science ®Google Scholar
• Wu NZ, Da D, Rudoll TL, Needham D, Whorton AR, Dewhirst MW. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 1993; 53: 3765–3770
   PubMed Web of Science ®Google Scholar
• Chen Q, Krol A, Wright A, Needham D, Dewhirst MW, Yuan F. Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. Int J Hyperthermia 2008; 24: 475–482
   PubMed Web of Science ®Google Scholar
• Kerr DJ, Kerr AM, Freshney RI, Kaye SB. Comparative intracellular uptake of adriamycin and 4′-deoxydoxorubicin by non-small cell lung tumor cells in culture and its relationship to cell survival. Biochem Pharmacol 1986; 35: 2817–2823
   PubMed Web of Science ®Google Scholar
• Ahmed M, Goldberg SN. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 2004; 20: 781–802
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Kanematsu T, Matsumata T, Takenaka K, Sugimachi K. Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection. Ann Surg 1989; 209: 297–301
   PubMed Web of Science ®Google Scholar
• Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999; 230: 1–8
   PubMed Web of Science ®Google Scholar
• van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, van der Sijp JR, van Gulik TM, Slooter GD, Klaase JM, et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 2006; 13: 651–658
   PubMed Web of Science ®Google Scholar
• Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 2007; 25: 978–986
   PubMed Web of Science ®Google Scholar
• Charrois GJ, Allen TM. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim Biophys Acta 2004; 1663: 167–177
   PubMed Web of Science ®Google Scholar
• Vora J, Boroujerdi M. Pharmacokinetic-toxicodynamic relationships of adriamycin in rat: Prediction of butylated hydroxyanisole-mediated reduction in anthracycline cardiotoxicity. J Pharm Pharmacol 1996; 48: 1264–1269
   PubMed Web of Science ®Google Scholar
• Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein GR, Freireich EJ. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 1982; 96: 133–139
   PubMed Web of Science ®Google Scholar
• Workman P. Infusional anthracyclines: Is slower better? If so, why?. Ann Oncol 1992; 3: 591–594
   PubMed Web of Science ®Google Scholar
• Cusack BJ, Young SP, Driskell J, Olson RD. Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit. Cancer Chemother Pharmacol 1993; 32: 53–58
   PubMed Web of Science ®Google Scholar
• de Valeriola D. Dose optimization of anthracyclines. Anticancer Res 1994; 14: 2307–2013
   PubMed Web of Science ®Google Scholar
• Dreher MR. Improving thermal ablation using novel drug and device combinations. Paper presented at the Society for Thermal Medicine Annual Meeting, Tucson, Arizona, April 4–6, 2009.
   Google Scholar
• Pritchard WF, Friedman MA, Karanian JW, Wray-Cahen D, Dewhirst M, Neeman Z, Hvizda J, Ashby A, Patel S, Kanter P, et al. Heat-sensitive liposomes as carriers for doxorubicin increase local drug deposition during radiofrequency ablation. Paper presented at the Radiological Society of North America Annual Meeting. Chicago November 28–December 3, 2003
   Google Scholar
• Tashjian JA, Dewhirst MW, Needham D, Viglianti BL. Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. Int J Hyperthermia 2008; 24: 79–90
   PubMed Web of Science ®Google Scholar
• Ames MM, Powis G, Kovach JS. Pharmacokinetics of anticancer agents in humans. Elsevier, Amsterdam 1983
   Google Scholar